Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Diabetic Peripheral Neuropathy - Overview Diabetic Peripheral Neuropathy - Therapeutics Development Pipeline Overview Pipeline by Companies Products under Development by Companies Diabetic Peripheral Neuropathy - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Diabetic Peripheral Neuropathy - Companies Involved in Therapeutics Development Achelios Therapeutics Inc Celgene Corp Commence Bio Inc Grunenthal GmbH Immune Pharmaceuticals Inc KPI Therapeutics Inc Medifron DBT Co Ltd Mitsubishi Tanabe Pharma Corp Novaremed Ltd Reata Pharmaceuticals Inc Relief Therapeutics Holding AG ViroMed Co Ltd Diabetic Peripheral Neuropathy - Drug Profiles (amitriptyline + ketamine hydrochloride) - Drug Profile Product Description Mechanism Of Action R&D Progress (diclofenac sodium + triclocarban) - Drug Profile Product Description Mechanism Of Action R&D Progress AAD-2004 - Drug Profile Product Description Mechanism Of Action R&D Progress atexakin alfa - Drug Profile Product Description Mechanism Of Action R&D Progress BNV-222 - Drug Profile Product Description Mechanism Of Action R&D Progress CMB-200 - Drug Profile Product Description Mechanism Of Action R&D Progress CNV-2197944 - Drug Profile Product Description Mechanism Of Action R&D Progress donaperminogene seltoplasmid - Drug Profile Product Description Mechanism Of Action R&D Progress ketoprofen - Drug Profile Product Description Mechanism Of Action R&D Progress KU-32 - Drug Profile Product Description Mechanism Of Action R&D Progress MDR-16523 - Drug Profile Product Description Mechanism Of Action R&D Progress MDR-652 - Drug Profile Product Description Mechanism Of Action R&D Progress MT-8554 - Drug Profile Product Description Mechanism Of Action R&D Progress NRD-135SE1 - Drug Profile Product Description Mechanism Of Action R&D Progress PDA-002 - Drug Profile Product Description Mechanism Of Action R&D Progress pirenzepine hydrochloride - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules for CNS Disorders, Toxicology and Metabolic Disorders - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules for Pain - Drug Profile Product Description Mechanism Of Action R&D Progress sodium nitrite SR - Drug Profile Product Description Mechanism Of Action R&D Progress U-2902 - Drug Profile Product Description Mechanism Of Action R&D Progress Diabetic Peripheral Neuropathy - Dormant Projects Diabetic Peripheral Neuropathy - Discontinued Products Diabetic Peripheral Neuropathy - Product Development Milestones Featured News & Press Releases Oct 30, 2017: VM BioPharma Announces Generic Name “donaperminogene seltoplasmid” for Investigational Novel Gene Therapy, VM202 Sep 25, 2017: ViroMed, Gene Therapy Powerhouse on Global Stage Sep 08, 2016: ViroMed proceeding with the

List of Tables Number of Products under Development for Diabetic Peripheral Neuropathy, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018 Products under Development by Companies, H1 2018 Products under Development by Companies, H1 2018 (Contd..1), H1 2018 Number of Products by Stage and Target, H1 2018 Number of Products by Stage and Mechanism of Action, H1 2018 Number of Products by Stage and Route of Administration, H1 2018 Number of Products by Stage and Molecule Type, H1 2018 Diabetic Peripheral Neuropathy - Pipeline by Achelios Therapeutics Inc, H1 2018 Diabetic Peripheral Neuropathy - Pipeline by Celgene Corp, H1 2018 Diabetic Peripheral Neuropathy - Pipeline by Commence Bio Inc, H1 2018 Diabetic Peripheral Neuropathy - Pipeline by Grunenthal GmbH, H1 2018 Diabetic Peripheral Neuropathy - Pipeline by Immune Pharmaceuticals Inc, H1 2018 Diabetic Peripheral Neuropathy - Pipeline by KPI Therapeutics Inc, H1 2018 Diabetic Peripheral Neuropathy - Pipeline by Medifron DBT Co Ltd, H1 2018 Diabetic Peripheral Neuropathy - Pipeline by Mitsubishi Tanabe Pharma Corp, H1 2018 Diabetic Peripheral Neuropathy - Pipeline by Novaremed Ltd, H1 2018 Diabetic Peripheral Neuropathy - Pipeline by Reata Pharmaceuticals Inc, H1 2018 Diabetic Peripheral Neuropathy - Pipeline by Relief Therapeutics Holding AG, H1 2018 Diabetic Peripheral Neuropathy - Pipeline by ViroMed Co Ltd, H1 2018 Diabetic Peripheral Neuropathy - Dormant Projects, H1 2018 Diabetic Peripheral Neuropathy - Discontinued Products, H1 2018 List of Figures Number of Products under Development for Diabetic Peripheral Neuropathy, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products by Top 10 Targets, H1 2018 Number of Products by Stage and Top 10 Targets, H1 2018 Number of Products by Top 10 Mechanism of Actions, H1 2018 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018 Number of Products by Routes of Administration, H1 2018 Number of Products by Stage and Routes of Administration, H1 2018 Number of Products by Molecule Types, H1 2018 Number of Products by Stage and Molecule Types, H1 2018

Achelios Therapeutics Inc Celgene Corp Commence Bio Inc Grunenthal GmbH Immune Pharmaceuticals Inc KPI Therapeutics Inc Medifron DBT Co Ltd Mitsubishi Tanabe Pharma Corp Novaremed Ltd Reata Pharmaceuticals Inc Relief Therapeutics Holding AG ViroMed Co Ltd